ICUI ICU Medical, Inc.

NASDAQ
$157.60

ICU Medical, Inc. (ICUI) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with ICUI's own trailing one-year pace, with 43% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 6 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
7
19 transactions
Purchases
$0
0 shares
Sales
$8.3M
49,624 shares
Net activity
-$8.3M
purchases less sales

How much of that selling was preplanned? 43% planned / 57% discretionary

10b5-1 plan sales $3.5M 9 transactions · 20,544 shares
Discretionary sales $4.7M 10 transactions · 29,080 shares

Largest single sale: $1.6M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: August 27, 2025 — 1.1 years ago, by Greenberg David C. .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Sanzone Virginia Ruth 4 fills VP, General Counsel Sell 10b5-1 4,856 $168.69 $819.2K 17,258 −22% of holding
Bonnell Brian Michael Chief Financial Officer Sell 10b5-1 6,381 $175.00 $1.1M 56,062 −10.2% of holding
Bonnell Brian Michael 4 fills Chief Financial Officer Sell 10b5-1 9,307 $172.79 $1.6M 70,038 −11.7% of holding
Woolson Daniel VP, GM-Infusion Capital Sell 5,417 $181.33 $982.3K 17,062 −24.1% of holding
Sousa Ben Chief Information Officer Sell 2,250 $178.32 $401.2K 3,076 −42.2% of holding
Voigtlander Christian B. Chief Operating Officer Sell 8,929 $182.93 $1.6M 37,377 −19.3% of holding
FINNEY ELISHA W Director Sell 378 $182.48 $69.0K 4,871 −7.2% of holding
Woolson Daniel President Sell 2,123 $132.21 $280.7K 22,479 −8.6% of holding
Sanzone Virginia Ruth VP, General Counsel Sell 2,447 $124.08 $303.6K 19,460 −11.2% of holding
Greenberg David C. Director Sell 2,424 $122.91 $297.9K 7,960 −23.3% of holding
Woolson Daniel VP, GM-Infusion Capital Sell 2,897 $152.35 $441.4K 11,297 −20.4% of holding
FINNEY ELISHA W Director Sell 1,285 $140.42 $180.4K 3,995 −24.3% of holding
Sanzone Virginia Ruth VP, General Counsel Sell 930 $142.34 $132.4K 5,456 −14.6% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.